Olesoxime
- CAS No.
- 22033-87-0
- Chemical Name:
- Olesoxime
- Synonyms
- TRO19266;NSC 21311;olesoxime;TRO 19622;Olesoxime (TRO-19622);Cholest-4-en-3-one oxime;Olesoxime, 10 mM in DMSO;OLESOXIME;NSC 21311;TRO19622;TRO-19622;Cholest-4-en-3-one, oxime, NSC 21311;Inhibitor,NSC21311,NSC-21311,TRO19622,Olesoxime,inhibit,TRO-19622,Mitochondrial Metabolism
- CBNumber:
- CB61254361
- Molecular Formula:
- C27H45NO
- Molecular Weight:
- 399.65
- MDL Number:
- MFCD00201488
- MOL File:
- 22033-87-0.mol
| Product description | Number | Pack Size | Price |
| TRO 19622 ≥98% (HPLC), solid | T3077 | 5mg | $145.35 |
| TRO 19622 ≥98% (HPLC), solid | T3077 | 25mg | $543 |
| TRO 19622 | T4208 | 10MG | $280 |
| TRO 19622 | T4208 | 50MG | $798 |
| TRO 19622 ≥95% (mixture of isomers) | 21264 | 10mg | $121 |
| Melting point | 145-148 ºC |
|---|---|
| Boiling point | 510.0±23.0 °C(Predicted) |
| Density | 1.10 |
| storage temp. | -20°C |
| solubility | DMSO: >10mg/mL |
| pka | 12.27±0.70(Predicted) |
| form | solid |
| color | white |
| Stability | Stable for 1 year as supplied. Solutions in DMSO or ethanol may be stored at -20°C for up to 3 months. |
| CAS DataBase Reference | 22033-87-0(CAS DataBase Reference) |
| FDA UNII | A6778U5IFY |
| UNSPSC Code | 12352200 |
| NACRES | NA.77 |
Olesoxime price More Price(22)
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| Sigma-Aldrich | T3077 | TRO 19622 ≥98% (HPLC), solid | 22033-87-0 | 5mg | $145.35 | 2025-07-31 | Buy |
| Sigma-Aldrich | T3077 | TRO 19622 ≥98% (HPLC), solid | 22033-87-0 | 25mg | $543 | 2025-07-31 | Buy |
| TCI Chemical | T4208 | TRO 19622 | 22033-87-0 | 10MG | $280 | 2025-07-31 | Buy |
| TCI Chemical | T4208 | TRO 19622 | 22033-87-0 | 50MG | $798 | 2025-07-31 | Buy |
| Cayman Chemical | 21264 | TRO 19622 ≥95% (mixture of isomers) | 22033-87-0 | 10mg | $121 | 2024-03-01 | Buy |
Olesoxime Chemical Properties,Uses,Production
Description
TRO19622 (22033-87-0) is a neuroregenerative and neuroprotective agent acting at components of the mitochondrial permeability transition pore (MPTP).1?Rescues motor neurons from axotomy-induced cell death and promotes nerve regeneration following sciatic nerve crush in mice. Reduces ROS and NLRP3 inflammasome activation in a mouse model of intracerebral hemorrhage.2?Inhibits MPTP opening and protects neurons from apoptosis.3?Induces oligodendrocyte maturation in culture and promotes myelin regeneration?in vivo?in a rodent model.4
Uses
TRO 19622 interacts with mitochondria proteins and is able to promote neuron survival under stress conditions. It is a potential drug for treating amyotrophic lateral sclerosis (ALS). TRO 19622 is a neuroregenerative and neuroprotective agent. This is a research product for neuroscience.
Uses
TRO 19622 has been used as a mitochondrial permeability transition pore inhibitor in mouse neurons2. TRO 19622 is also known to stimulate myelin repair in rat models of demyelination3.
Biological Activity
Neuroprotective and neuroregenerative compound. Rescues motor neurons from axotomy-induced cell death and promotes nerve regeneration following sciatic nerve crush in vivo . Binds directly to two components of the mitochondrial permeability pore, the voltage-dependent anion channel (VDAC) and translocator protein.
Biochem/physiol Actions
TRO 19622 can decrease axonal degradation and enhance the rescue of motor nerve conduction in peripheral neuropathy. Furthermore, TRO 19622 can reverse neuropathic pain and tactile allodynia in rat models of diabetes and chemotherapy-induced neuropathic pain4.
storage
Desiccate at +4°C
References
[1] THIERRY BORDET. Identification and characterization of cholest-4-en-3-one, oxime (TRO19622), a novel drug candidate for amyotrophic lateral sclerosis.[J]. ACS Applied Electronic Materials, 2007: 709-720. DOI:10.1124/jpet.107.123000
[2] QINGYI MA PHD Qin H M Sheng Chen MD, PHD John H Z M Hua Feng MD, PHD Jiping T M. NLRP3 inflammasome contributes to inflammation after intracerebral hemorrhage[J]. Annals of Neurology, 2013, 75 2: 209-219. DOI:10.1002/ana.24070
[3] LEE J MARTIN. The mitochondrial permeability transition pore regulates nitric oxide-mediated apoptosis of neurons induced by target deprivation.[J]. Journal of Neuroscience, 2011, 31 1: 359-370. DOI:10.1523/jneurosci.2225-10.2011
[4] K. MAGALON . Olesoxime favors oligodendrocyte differentiation through a functional interplay between mitochondria and microtubules[J]. Neuropharmacology, 2016, 111: Pages 293-303. DOI:10.1016/j.neuropharm.2016.09.009
Olesoxime Preparation Products And Raw materials
Raw materials
Preparation Products
Olesoxime Suppliers
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| TargetMol Chemicals Inc. | +1-781-999-5354; +17819995354 | marketing@targetmol.com | United States | 32435 | 58 |
| InvivoChem | +1-708-310-1919 +1-13798911105 | sales@invivochem.cn | United States | 6391 | 58 |
| HANGZHOU LEAP CHEM CO., LTD. | +86-571-87711850 | market18@leapchem.com | China | 24727 | 58 |
| Hangzhou MolCore BioPharmatech Co.,Ltd. | +86-057181025280; +8617767106207 | sales@molcore.com | China | 49734 | 58 |
| TargetMol Chemicals Inc. | +1-781-999-5354; | support@targetmol.com | United States | 39035 | 58 |
| Shanghai Acmec Biochemical Technology Co., Ltd. | +86-18621343501; +undefined18621343501 | product@acmec-e.com | China | 33337 | 58 |
| Aladdin Scientific | tp@aladdinsci.com | United States | 57505 | 58 | |
| SHANGHAI KEAN TECHNOLOGY CO., LTD. | +8613817748580 | cooperation@kean-chem.com | China | 40066 | 58 |
| Mainchem Co., Ltd. | +86-0592-6210733 | sale@mainchem.com | China | 32343 | 55 |
| 3B Pharmachem (Wuhan) International Co.,Ltd. | 821-50328103-801 18930552037 | 3bsc@sina.com | China | 15838 | 69 |
